| NCT03775499 |
Probiotic BL NCC 2705 and Gluten Sensitivity |
https://ClinicalTrials.gov/show/NCT03775499 |
Active, not recruiting |
Nestlé |
2019-10-04 |
| NCT03409796 |
Assessment of Immune Activation and Tolerance in Celiac Disease |
https://ClinicalTrials.gov/show/NCT03409796 |
Completed |
Takeda |
2019-05-02 |
| NCT03380988 |
Fiber-enriched Buckwheat Pasta and Glucose Variability in Patients With Type 1 Diabetes and Celiac Disease |
https://ClinicalTrials.gov/show/NCT03380988 |
Completed |
Federico II University |
2016-12-31 |
| NCT03321214 |
Gluten Sensor Device to Promote Gluten Free Diet Adherence and Quality of Life in Patients With Celiac Disease |
https://ClinicalTrials.gov/show/NCT03321214 |
Completed |
Columbia University |
2018-10-31 |
| NCT03288831 |
Changes in Intestinal Permeability 4 Hours After Gluten Challenge |
https://ClinicalTrials.gov/show/NCT03288831 |
Completed |
Mayo Clinic |
2018-10-30 |
| NCT03271138 |
Bifidobacterium Infantis NLS Super Strain for Celiac Disease Patients on a Gluten-free Diet With Persistent Gastrointestinal Symptoms |
https://ClinicalTrials.gov/show/NCT03271138 |
Completed |
Global Institute of Probiotics |
2017-12-07 |
| NCT03176095 |
Celiac Disease Prevention With Probiotics |
https://ClinicalTrials.gov/show/NCT03176095 |
Completed |
Lund University |
2015-08-30 |
| NCT03064997 |
Prebiotic as a Supplement of Gluten-free Diet in the Management of Celiac Disease in Children |
https://ClinicalTrials.gov/show/NCT03064997 |
Completed |
Polish Academy of Sciences |
2016-03-01 |
| NCT03037190 |
Preservation of Residual Beta Cell Mass and Prevention of Celiac Disease in Children With Recent Onset Type 1 Diabetes |
https://ClinicalTrials.gov/show/NCT03037190 |
Recruiting |
Lund University |
2020-12-31 |
| NCT03011931 |
Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568] |
https://ClinicalTrials.gov/show/NCT03011931 |
Completed |
Immunogenics, LLC |
2019-01-31 |
| NCT03011593 |
Effect of UGIR in Adults With Compromised Gut Function and Malabsorption |
https://ClinicalTrials.gov/show/NCT03011593 |
Completed |
Metagenics, Inc. |
2016-06-30 |
| NCT02965209 |
European Novel Motorized Spiral Endoscopy Trial |
https://ClinicalTrials.gov/show/NCT02965209 |
Completed |
Evangelisches Krankenhaus Düsseldorf |
2018-02-03 |
| NCT02895438 |
Non Coeliac Gluten Sensitivity in Children |
https://ClinicalTrials.gov/show/NCT02895438 |
Completed |
Centre Hospitalier Universitaire de Saint Etienne |
2017-10-04 |
| NCT02764931 |
Gluten-free Oats and Gastrointestinal Health in Coeliac Disease, Part 1 |
https://ClinicalTrials.gov/show/NCT02764931 |
Recruiting |
University of Turku |
2019-12-31 |
| NCT02754609 |
Hookworm Therapy for Coeliac Disease |
https://ClinicalTrials.gov/show/NCT02754609 |
Completed |
James Cook University, Queensland, Australia |
2019-10-31 |
| NCT02711696 |
Randomized Clincal Trial on the Effect of a Restricted Gluten Contamination Elimination Diet Among Celiacs [GluCED] |
https://ClinicalTrials.gov/show/NCT02711696 |
Completed |
Università degli Studi di Brescia |
2015-06-30 |
| NCT02679014 |
A Study to Investigate the Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Repeated Dosing of RO5459072 in Volunteers With Celiac Disease |
https://ClinicalTrials.gov/show/NCT02679014 |
Completed |
Hoffmann-La Roche |
2016-08-28 |
| NCT02675283 |
Case Finding for Coeliac Disease Using a Point of Care Test in a Pharmacy Setting |
https://ClinicalTrials.gov/show/NCT02675283 |
Completed |
Sheffield Teaching Hospitals NHS Foundation Trust |
2017-10-31 |
| NCT02637141 |
A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease |
https://ClinicalTrials.gov/show/NCT02637141 |
Completed |
Amgen |
2017-02-15 |
| NCT02633020 |
Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease |
https://ClinicalTrials.gov/show/NCT02633020 |
Completed |
Amgen |
2017-04-11 |
| NCT02612766 |
Safety and Tolerability of Oat Containing Gluten-free Diet |
https://ClinicalTrials.gov/show/NCT02612766 |
Completed |
Alfred Rusescu Institute for Mother and Child Care |
2016-12-31 |
| NCT02528799 |
Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease |
https://ClinicalTrials.gov/show/NCT02528799 |
Completed |
ImmusanT, Inc. |
2017-01-06 |
| NCT02472704 |
Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo |
https://ClinicalTrials.gov/show/NCT02472704 |
Completed |
Hospital Mutua de Terrassa |
2014-04-30 |
| NCT02458898 |
Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease |
https://ClinicalTrials.gov/show/NCT02458898 |
Completed |
Stanford University |
2016-05-31 |
| NCT02344758 |
Gluten-free Diet Monitoring in Urine |
https://ClinicalTrials.gov/show/NCT02344758 |
Completed |
University of Seville |
2013-07-31 |
| NCT02244047 |
Cytokine Profile in Children With Celiac Disease |
https://ClinicalTrials.gov/show/NCT02244047 |
Completed |
University Medical Centre Maribor |
2014-06-30 |
| NCT02220166 |
Safety of Prolonged Administration of Triticum Monococcum in Celiac Disease |
https://ClinicalTrials.gov/show/NCT02220166 |
Completed |
Università degli Studi di Brescia |
2011-07-31 |
| NCT02202681 |
Imaging the Duodenum Using an Optical Frequency Domain Imaging OFDI Capsule |
https://ClinicalTrials.gov/show/NCT02202681 |
Recruiting |
Massachusetts General Hospital |
2020-07-31 |
| NCT01317914 |
Prospective Study of Undiagnosed Celiac Disease |
https://ClinicalTrials.gov/show/NCT01317914 |
Completed |
Mayo Clinic |
2012-04-30 |
| NCT01990885 |
Safety and Systemic Exposure Study of BL-7010 in Well-Controlled Celiac Patients. |
https://ClinicalTrials.gov/show/NCT01990885 |
Completed |
BioLineRx, Ltd. |
2014-10-31 |
| NCT03351972 |
Differences in Preparation for Small Bowel Capsule Endoscopy |
https://ClinicalTrials.gov/show/NCT03351972 |
Recruiting |
Sheffield Teaching Hospitals NHS Foundation Trust |
2019-11-01 |
| NCT01932476 |
Gluten Immunity and Islet Autoimmunity in Type-1 Diabetes |
https://ClinicalTrials.gov/show/NCT01932476 |
Completed |
Joslin Diabetes Center |
2014-12-31 |
| NCT01893775 |
Antibody Treatment for Advanced Celiac Disease |
https://ClinicalTrials.gov/show/NCT01893775 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-12-20 |
| NCT01787825 |
Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Disease |
https://ClinicalTrials.gov/show/NCT01787825 |
Completed |
Capso Vision, Inc. |
2015-04-30 |
| NCT01765647 |
Oral AGY for Celiac Disease |
https://ClinicalTrials.gov/show/NCT01765647 |
Completed |
Igy Inc. |
2015-08-31 |
| NCT01762579 |
Bio-markers of Not-celiac Wheat Sensitivity |
https://ClinicalTrials.gov/show/NCT01762579 |
Recruiting |
University of Palermo |
2016-01-01 |
| NCT01762566 |
Bioelectrical Impedance Analysis of Not-celiac Wheat Sensitivity Patients |
https://ClinicalTrials.gov/show/NCT01762566 |
Completed |
University of Palermo |
2013-10-31 |
| NCT01695681 |
Screen-detected Coeliac Disease, a Population Based Study |
https://ClinicalTrials.gov/show/NCT01695681 |
Completed |
University Hospital of North Norway |
2015-04-15 |
| NCT01661933 |
Desensitising Celiac Disease Patients With the Human Hookworm |
https://ClinicalTrials.gov/show/NCT01661933 |
Completed |
The Prince Charles Hospital |
2014-03-31 |
| NCT01566110 |
Celiac Disease and Diabetes- Dietary Intervention and Evaluation Trial |
https://ClinicalTrials.gov/show/NCT01566110 |
Completed |
The Hospital for Sick Children |
2018-03-31 |
| NCT01558557 |
Gluten Free Diet in People With Schizophrenia: A Pilot Study |
https://ClinicalTrials.gov/show/NCT01558557 |
Completed |
University of Maryland, Baltimore |
2014-01-31 |
| NCT01439035 |
Evaluate the Use of Optical Frequency Domain Imaging (OFDI) for Celiac Disease in Children, Adolescents and Young Adults |
https://ClinicalTrials.gov/show/NCT01439035 |
Completed |
Massachusetts General Hospital |
2010-02-04 |
| NCT01396213 |
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease |
https://ClinicalTrials.gov/show/NCT01396213 |
Completed |
Innovate Biopharmaceuticals |
2013-08-20 |
| NCT01338324 |
Protocol for Correlating Enteropathic Severity and Small Intestinal CYP3A4 Activity in Patients With Celiac Disease |
https://ClinicalTrials.gov/show/NCT01338324 |
Completed |
All India Institute of Medical Sciences, New Delhi |
2011-06-30 |
| NCT04248855 |
Evaluation of KAN-101 in Celiac Disease |
https://ClinicalTrials.gov/show/NCT04248855 |
Recruiting |
Anokion SA |
2020-11-30 |
| NCT04243551 |
Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD Patients |
https://ClinicalTrials.gov/show/NCT04243551 |
Recruiting |
Immunogenics, LLC |
2021-06-30 |
| NCT04160767 |
Celiac Disease and Vitamin Status: Evaluation of the Effect of Supplementation With a Probiotic (VIVOMIXX®) in a Cohoort of Celiac Patients |
https://ClinicalTrials.gov/show/NCT04160767 |
Recruiting |
University of Milan |
2021-01-31 |
| NCT04041622 |
Coeliac Disease in the Nord-Trøndelag Health Study (HUNT) |
https://ClinicalTrials.gov/show/NCT04041622 |
Recruiting |
Norwegian University of Science and Technology |
2021-07-31 |
| NCT04014660 |
Prevention av Autoimmunitet Med Laktobaciller |
https://ClinicalTrials.gov/show/NCT04014660 |
Recruiting |
Lund University |
2021-12-31 |
| NCT04014413 |
Safety and Efficacy of Fecal Microbiota Transplantation |
https://ClinicalTrials.gov/show/NCT04014413 |
Recruiting |
Chinese University of Hong Kong |
2023-10-31 |
| NCT03866538 |
Budesonide in Patients With Immune Mediated Enteropathies |
https://ClinicalTrials.gov/show/NCT03866538 |
Recruiting |
Mayo Clinic |
2020-09-01 |
| NCT03857360 |
Effectiveness of PENTABIOCEL in Clinical and Laboratory Recovery of Children With Celiac Disease |
https://ClinicalTrials.gov/show/NCT03857360 |
Recruiting |
Università Politecnica delle Marche |
2021-03-15 |
| NCT03763487 |
The Aim of This Project is to Verify Whether a Depletion of B Cell Memory Subpopulation (“Marginal-zone-like”) CD19 + IgD + CD27 + and CD19 + IgM + CD27 + is a Useful Indicator of Hyposplenism in Patients With Celiac Disease |
https://ClinicalTrials.gov/show/NCT03763487 |
Recruiting |
University Hospital Hradec Kralove |
2018-12-31 |
| NCT03707730 |
A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease |
https://ClinicalTrials.gov/show/NCT03707730 |
Recruiting |
Igy Inc. |
2022-12-31 |
| NCT03701555 |
Assess the Safety, Tolerability, Pharmacokinetics (PK), and Gluten Degradation Activity of PvP001, PvP002, and PvP003 in Healthy Adult Volunteers and to Assess the Safety, Tolerability, and PK of PvP001 and PvP002 in Adults With Celiac Disease (CeD) |
https://ClinicalTrials.gov/show/NCT03701555 |
Recruiting |
Takeda |
2020-08-31 |
| NCT03678935 |
Effect of FODMAP Restriction on Persistent GI-symptoms in Coeliac Patients |
https://ClinicalTrials.gov/show/NCT03678935 |
Active, not recruiting |
Oslo University Hospital |
2019-06-01 |
| NCT03644602 |
Low FODMAPs Diet in Gastrointestinal Disorders |
https://ClinicalTrials.gov/show/NCT03644602 |
Completed |
Federico II University |
2016-12-31 |
| NCT03644069 |
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) |
https://ClinicalTrials.gov/show/NCT03644069 |
Active, not recruiting |
ImmusanT, Inc. |
2019-09-30 |
| NCT03585478 |
Latiglutenase as a Treatment for Celiac Disease |
https://ClinicalTrials.gov/show/NCT03585478 |
Recruiting |
Immunogenics, LLC |
2020-02-29 |
| NCT03543540 |
Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease |
https://ClinicalTrials.gov/show/NCT03543540 |
Completed |
ImmusanT, Inc. |
2018-09-10 |
| NCT03520244 |
A 12-week Exercise Program for Adults With Celiac Disease |
https://ClinicalTrials.gov/show/NCT03520244 |
Completed |
University of Calgary |
2018-03-30 |
| NCT03486990 |
Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease |
https://ClinicalTrials.gov/show/NCT03486990 |
Completed |
Takeda |
2019-05-24 |
| NCT03483805 |
Effects of a Nutritional Solution to Improve Intestinal Permeability in Celiac Patients |
https://ClinicalTrials.gov/show/NCT03483805 |
Completed |
Société Guaranteed Gluten Free (GGF) |
2018-01-12 |
| NCT03462979 |
Effects of Home Gluten Immunogenic Peptide Testing on Children With Celiac Disease |
https://ClinicalTrials.gov/show/NCT03462979 |
Recruiting |
Boston Children’s Hospital |
2021-12-31 |
| NCT01257620 |
Clinical Trial on the Effects of Bifidobacterium Infantis in Active Celiac Disease |
https://ClinicalTrials.gov/show/NCT01257620 |
Completed |
Bai, Julio M.D. |
2011-09-30 |
| NCT01255696 |
Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease |
https://ClinicalTrials.gov/show/NCT01255696 |
Completed |
Alvine Pharmaceuticals Inc. |
2011-05-31 |
| NCT01137955 |
Rifaximin for the Treatment of Persistent Symptoms in Patients With Celiac Disease |
https://ClinicalTrials.gov/show/NCT01137955 |
Completed |
Columbia University |
2008-04-30 |
| NCT01116505 |
Treatment of Screen-detected Celiac Disease |
https://ClinicalTrials.gov/show/NCT01116505 |
Completed |
Tampere University Hospital |
2012-07-31 |
| NCT01100099 |
HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease |
https://ClinicalTrials.gov/show/NCT01100099 |
Completed |
Oslo University Hospital |
2009-12-31 |
| NCT01094041 |
Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT01094041 |
Completed |
Mayo Clinic |
2012-01-31 |
| NCT01045837 |
Effect of Addition of Short Course of Prednisolone to Gluten Free Diet in Naive Celiac Disease Patients |
https://ClinicalTrials.gov/show/NCT01045837 |
Completed |
All India Institute of Medical Sciences, New Delhi |
2010-04-30 |
| NCT00962182 |
Study of Enzyme Supplements to Treat Celiac Disease |
https://ClinicalTrials.gov/show/NCT00962182 |
Completed |
Heim Pal Children’s Hospital |
2014-12-31 |
| NCT00959114 |
Safety and Efficacy of ALV003 for the Treatment of Celiac Disease |
https://ClinicalTrials.gov/show/NCT00959114 |
Completed |
Alvine Pharmaceuticals Inc. |
2010-08-31 |
| NCT00931892 |
Serum Markers in Gluten Challenge |
https://ClinicalTrials.gov/show/NCT00931892 |
Completed |
Beth Israel Deaconess Medical Center |
2011-08-31 |
| NCT00889473 |
Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease |
https://ClinicalTrials.gov/show/NCT00889473 |
Completed |
Innovate Biopharmaceuticals |
2009-11-30 |
| NCT00879749 |
Safety Study of Nexvax2 in Subjects With Coeliac Disease |
https://ClinicalTrials.gov/show/NCT00879749 |
Completed |
Nexpep Pty Ltd |
2010-03-31 |
| NCT03738475 |
Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease |
https://ClinicalTrials.gov/show/NCT03738475 |
Active, not recruiting |
COUR Pharmaceutical Development Company, Inc. |
2019-07-31 |
| NCT02389062 |
Noninvasive Markers of Gluten Ingestion in Celiac Disease Patients |
https://ClinicalTrials.gov/show/NCT02389062 |
Completed |
Thomas Jefferson University |
2016-02-11 |
| NCT00810654 |
Effect of Aspergillus Niger Prolyl Endoprotease (AN-PEP) Enzyme on the Effects of Gluten Ingestion in Patients With Coeliac Disease |
https://ClinicalTrials.gov/show/NCT00810654 |
Completed |
VU University Medical Center |
2009-05-31 |
| NCT03137862 |
“Gluten Friendly” Treatment in Celiac Disease |
https://ClinicalTrials.gov/show/NCT03137862 |
Completed |
Casa Sollievo della Sofferenza IRCCS |
2017-04-02 |
| NCT03562221 |
Prevention of Celiac Disease in Skåne |
https://ClinicalTrials.gov/show/NCT03562221 |
Recruiting |
Lund University |
2024-08-31 |
| NCT03569007 |
Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms |
https://ClinicalTrials.gov/show/NCT03569007 |
Recruiting |
Innovate Biopharmaceuticals |
2021-08-31 |
| NCT00677495 |
Gluten-free Diet in Gluten-genetically Predisposed Subjects |
https://ClinicalTrials.gov/show/NCT00677495 |
Active, not recruiting |
IRCCS Burlo Garofolo |
2019-12-31 |
| NCT00671138 |
Inoculating Celiac Disease Patients With the Human Hookworm Necator Americanus: Evaluating Immunity and Gluten-sensitivity |
https://ClinicalTrials.gov/show/NCT00671138 |
Completed |
Princess Alexandra Hospital, Brisbane, Australia |
2008-12-31 |
| NCT00669825 |
Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal |
https://ClinicalTrials.gov/show/NCT00669825 |
Completed |
Alvine Pharmaceuticals Inc. |
2008-10-31 |
| NCT00639444 |
Risk of Celiac Disease and Age at Gluten Introduction |
https://ClinicalTrials.gov/show/NCT00639444 |
Completed |
Università Politecnica delle Marche |
2007-12-31 |
| NCT00628823 |
Treatment of Mild Enteropathy Celiac Disease |
https://ClinicalTrials.gov/show/NCT00628823 |
Completed |
Tampere University Hospital |
2008-06-30 |
| NCT00626184 |
A Phase 1, Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease |
https://ClinicalTrials.gov/show/NCT00626184 |
Completed |
Alvine Pharmaceuticals Inc. |
2008-05-31 |
| NCT00620451 |
Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease |
https://ClinicalTrials.gov/show/NCT00620451 |
Completed |
Innovate Biopharmaceuticals |
2009-07-31 |
| NCT00540657 |
A Phase II Study of CCX282-B in Patients With Celiac Disease |
https://ClinicalTrials.gov/show/NCT00540657 |
Completed |
ChemoCentryx |
2008-06-30 |
| NCT00492960 |
Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease |
https://ClinicalTrials.gov/show/NCT00492960 |
Completed |
Innovate Biopharmaceuticals |
2008-10-31 |
| NCT00386165 |
Safety Study of Larazotide Acetate to Treat Celiac Disease. |
https://ClinicalTrials.gov/show/NCT00386165 |
Completed |
Innovate Biopharmaceuticals |
2006-01-26 |
| NCT00362856 |
Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects |
https://ClinicalTrials.gov/show/NCT00362856 |
Completed |
Innovate Biopharmaceuticals |
2007-03-06 |